The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 89.62%.However, over the last six months, we can see a weaker performance of 55.03%. Over the last 30 days, the price of CDMO has fallen by 21.07%. And in the last five days, it has surged by 0.86%.
Avid Bioservices Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $12.48 on 09/19/24 and the lowest value was $4.07 on 12/08/23.
52-week price history of CDMO Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Avid Bioservices Inc’s current trading price is -1.24% away from its 52-week high, while its distance from the 52-week low is 202.79%. The stock’s price range during this period has varied between$4.07 and $12.48. The Avid Bioservices Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.0 million for the day, a figure considerably lower than their average daily volume of 1.79 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Avid Bioservices Inc (CDMO) has experienced a quarterly rise of 18.97% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 788.25M and boasts a workforce of 371 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.61, with a change in price of +4.74. Similarly, Avid Bioservices Inc recorded 1,532,694 in trading volume during the last 100 days, posting a change of +62.60%.
CDMO’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CDMO stands at 3.54. Similarly, the long-term debt-to-equity ratio is also 3.49.
CDMO Stock Stochastic Average
Avid Bioservices Inc’s raw stochastic average for the past 50 days is presently 94.11%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 98.95%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 98.81% and 98.49%, respectively.
